Kolmar Korea's stock climbed as much as 27.06% intraday that day, and Cosmax rose 16.90%. On a closing-price basis, the gains were smaller — about 22.8% for Kolmar Korea and 18.8% for Cosmax. Intraday and closing figures need to be kept separate, but either way, both stocks were sharply re-rated in a single session.
It's hard to attribute the rally to a single line of government trade data, though. Cosmax had already announced record earnings and its U.S. subsidiary's first quarterly profit on August 11, and Kolmar Korea followed on August 12 with second-quarter results that beat market expectations. It's more accurate to read the surge as export data, earnings beats, and brokerages raising their forecasts all landing around the same time.
What the market confirmed was twofold: K-beauty's export growth isn't confined to a handful of famous brands, and the ODM companies that develop and manufacture products for a huge roster of brands have become the core infrastructure behind that growth.
ODM: The Manufacturing Platform Growing Behind the Brands
ODM stands for original development manufacturing. Unlike OEM, where a company simply manufactures a product the brand has already designed, an ODM company handles a much wider scope — formulation development, ingredient selection, stability testing, production, and quality control.
Consumers see the brand name on the finished product, but the company that actually developed and manufactured it may be an ODM maker like Cosmax, Kolmar Korea, or Cosmecca Korea. Part of what let K-beauty indie brands multiply so quickly is exactly this industry structure — a brand can tap a specialized ODM maker's R&D and production lines instead of building its own factory.
The three companies' strategies differ somewhat.
Cosmax leads with its global production network and R&D capabilities. Per its most recent disclosures, it has roughly 5,000 clients in Korea and abroad combined, exports directly to 34 countries, and supplies products to more than 100 countries through its clients. In 2026, it acquired a 51% stake in Italian ODM maker Cheminova, giving it a manufacturing foothold in Europe as well.
Kolmar Korea is betting on a platform strategy built around speed. Planet147 is an incubating platform that supports product development and brand launches, while PPS shortens time-to-market by combining pre-developed formulations and packaging. According to the company, PPS can compress a development cycle that normally takes nine to twelve months down to three to six.
Cosmecca Korea is building its growth around K-derma skincare, expanding its base of small and mid-sized clients, and its U.S. manufacturing subsidiary's capabilities in OTC and high-functionality products. This quarter, new clients and product lines grew mainly at its domestic entity, lifting both revenue and profit.
The Second Quarter, By the Numbers
| Segment | Revenue | Operating Profit | Notes |
|---|
| Cosmax, consolidated | KRW 794.9B (+27.5%) | KRW 73.7B (+21.3%) | U.S. subsidiary's first-ever quarterly profit |
| Kolmar Korea, standalone | KRW 430.4B (+31.2%) | KRW 70.8B (+44.3%) | Core domestic cosmetics ODM business |
| Kolmar Korea, consolidated | KRW 861.3B (+17.9%) | KRW 110.3B (+50.2%) | Includes HK inno.N, Yonwoo, and others |
| Cosmecca Korea, consolidated | KRW 226.1B (+39.8%) | KRW 32.1B (+about 39%) | Rising orders from K-derma, indie brands |
All three companies posted record quarterly results. Cosmax's Korean entity topped KRW 500 billion in quarterly revenue for the first time, and its U.S. subsidiary posted KRW 53.8 billion in revenue while turning its first quarterly operating profit since the company was founded. Its China subsidiary's revenue also rose 33% year-over-year to KRW 197.4 billion.
Kolmar Korea's standalone and consolidated figures need to be read separately. The standalone results show the growth of the core domestic cosmetics ODM business, while the consolidated figures also fold in HK inno.N and packaging subsidiary Yonwoo. Consolidated operating profit crossing KRW 100 billion for the first time — hitting KRW 110.3 billion in Q2 — reflects not just the domestic cosmetics business but also higher profit at HK inno.N and Yonwoo's swing to profitability.
A simple calculation puts operating margins at 9.3% for Cosmax (consolidated), 16.4% for Kolmar Korea (standalone), 12.8% for Kolmar Korea (consolidated), and 14.2% for Cosmecca Korea (consolidated). These figures shouldn't be read directly as a ranking of manufacturing competitiveness, though — each company's scope of consolidation, share of overseas subsidiaries, product mix, and client base all differ.
The U.S. business is where the divergence was sharpest. Cosmax's U.S. subsidiary grew revenue 79% and turned its first quarterly profit, while Kolmar Korea's U.S. subsidiary saw revenue slip 2.9% to KRW 17.8 billion and posted an operating loss of KRW 1.4 billion. A record quarter at the group level doesn't mean every overseas subsidiary improved in step.
Key Insight #1 — Broader Exposure to K-Beauty's Growth Than Any Single Brand
An ODM maker's biggest advantage is its client portfolio. If one brand succeeds in the U.S., its ODM orders grow; if another brand's sales slow, orders from new brands or new products can absorb part of the shock.
That's why ODM can be seen as a business with broader exposure to the growth of the entire K-beauty ecosystem, rather than to any single brand. That doesn't automatically make it a safer business, though. If client order declines, unit-price cuts, rising raw material costs, and falling factory utilization all hit at once, an ODM maker's profit can shrink quickly. Overseas production sites are both a growth foundation and a fixed-cost burden.
So far, the portfolio effect has been working in the industry's favor. According to Korea's Ministry of Food and Drug Safety, first-half 2026 cosmetics exports rose 27.3% year-over-year to $7.0 billion, a first-half record. Exports to the U.S. grew 41.5% to $1.45 billion, with the U.S. holding its position as the largest market at 20.7% of total exports.
Exports from small and mid-sized cosmetics companies also grew 30.7% in the first half, to $5.069 billion. That points to a structure where export growth is increasingly driven by a wide field of indie brands rather than one or two large conglomerates. Indie-brand growth doesn't translate one-to-one into ODM order growth, but it's currently pointing in the same direction as the three ODM makers' record results.
Key Insight #2 — Tariff Relief, and the Difference Local Production Makes
Following the U.S. tariff overhaul in April 2026, Korean-made cosmetics were reported to face a flat 10% global tariff. Even products classified as steel, aluminum, or copper derivatives are exempt from Section 232 tariffs if the relevant metal makes up less than 15% of the product's total weight.
That doesn't mean every cosmetics product and its packaging are automatically exempt, though. The actual tariff depends on each product's HS code, origin requirements, metal content, and how U.S. Customs classifies it. A company's real tariff burden has to be checked item by item.
Kolmar Korea's local U.S. production capacity is a separate advantage entirely. The company brought its second U.S. plant online in Scott Township, Pennsylvania, in July 2025. That plant has annual capacity of 120 million units, bringing combined U.S. capacity — with the existing first plant — to roughly 300 million units a year. Including its Canadian subsidiary, North American capacity totals about 470 million units.
Local production can reduce the tariff burden that comes with exporting from Korea to the U.S., and shorten delivery times and customer response times. But owning a plant doesn't guarantee results on its own. In Q2 2026, Kolmar Korea's U.S. subsidiary was still posting losses, and utilization remained low. In the end, the metric that matters isn't production capacity itself but new client acquisition, plant utilization, product mix, and when the subsidiary reaches breakeven.
Can Korea Overtake France?
Korea's exports of basic and color cosmetics (HS code 3304) rose 21% year-over-year to $4,639.62 million in the January-May 2026 period. France's exports fell 2% to $5,082.84 million over the same span. The gap between the two countries narrowed to $443.22 million.
If this pace holds, some forecasts see Korea overtaking France within a year or two. But the scope of that comparison needs to be stated clearly — it's limited to basic and color cosmetics exports. Looking at total beauty exports, including perfume and haircare, France's 2025 exports stood at $24.3 billion versus Korea's $11.4 billion — still a wide gap.
So the more accurate framing isn't "Korea is becoming the world's No. 1 cosmetics exporter," but "Korea is closing the gap with France in basic and color cosmetics exports."
The Remaining Variables: Client Concentration and Utilization
Client diversification is clearly a risk-reducing factor for ODM makers. But a large client count doesn't necessarily mean revenue is evenly distributed among them. This quarter's results at Kolmar Korea's U.S. subsidiary confirmed that a swing in orders from a few large clients can shake up a specific overseas unit's performance significantly.
There's also the possibility that a brand, once it scales up, moves to in-house production. But building your own plant means heavy capital investment, quality-control responsibility, regulatory exposure, and the risk of low utilization. So a large brand's growth doesn't automatically mean it will fully replace its ODM partner. A hybrid model may spread instead — manufacturing core products in-house while leaving new products and a wide range of SKUs to ODM makers.
The metrics worth tracking in future earnings aren't the client count itself, but the revenue share of top clients, order repeat rates, the number of new SKUs, factory utilization, and overseas subsidiaries' profit and cash flow.
✦RIT's Insights
What RIT found most notable in this round of earnings is that trade data and corporate results pointed in the same direction at the same time. Explaining the August 12 stock surge with a single line of trade data alone isn't accurate — it's closer to export growth, record earnings, profit beats, and improving expectations for the U.S. subsidiaries all landing together.
The second point is that ODM companies carry broader exposure to the entire K-beauty ecosystem than to any single brand. Serving many brands and products spreads out the risk of any one brand failing, but it doesn't erase the fixed costs and pricing pressure inherent to a capital-intensive manufacturing business. The more accurate framing isn't "safer than a brand," but "a different kind of risk."
The third is Kolmar Korea's U.S. production capacity. A facility that can produce 300 million units a year in the U.S. is a solid foundation for reducing tariff and delivery risk. But its U.S. subsidiary was still unprofitable in Q2 2026. What matters more than having built that capacity is how many orders fill it, and when it turns durably profitable.
Ultimately, the next stage of growth for the three ODM makers won't be completed just by building more plants. The key is whether they can convert that added capacity into repeat client orders and sustained cash flow. Next quarter, RIT will be watching not just revenue growth but U.S. subsidiary utilization, client concentration, overseas operating profit, and whether new projects actually convert into mass production.
